Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Return on Equity (2016 - 2018)

Armata Pharmaceuticals' Return on Equity history spans 5 years, with the latest figure at 0.4% for Q3 2018.

  • For Q3 2018, Return on Equity rose 106.0% year-over-year to 0.4%; the TTM value through Sep 2018 reached 0.4%, up 106.0%, while the annual FY2017 figure was 0.33%, N/A changed from the prior year.
  • Return on Equity for Q3 2018 was 0.4% at Armata Pharmaceuticals, down from 0.15% in the prior quarter.
  • Across five years, Return on Equity topped out at 3.37% in Q3 2014 and bottomed at 79.08% in Q1 2015.
  • The 5-year median for Return on Equity is 0.67% (2016), against an average of 5.11%.
  • The largest annual shift saw Return on Equity crashed -7987bps in 2015 before it surged 7808bps in 2016.
  • A 5-year view of Return on Equity shows it stood at 5.86% in 2014, then skyrocketed by 88bps to 0.72% in 2015, then fell by -6bps to 0.76% in 2016, then skyrocketed by 56bps to 0.34% in 2017, then fell by -17bps to 0.4% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Return on Equity are 0.4% (Q3 2018), 0.15% (Q2 2018), and 0.28% (Q1 2018).